Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Aging reprograms the functional, epigenetic, and metabolic landscape of macrophages.

Research square·2026
Same author

Macrophage-Centric Phenotypic Screening Identifies Tetrazolone-Based HDAC6 Inhibitors That Reprogram the Tumor Immune Microenvironment and Improve Immune Checkpoint Blockade.

Journal of medicinal chemistry·2026
Same author

The voice of the plateau: a qualitative interview study of student management and educational practices in higher education in Xizang Autonomous Region.

Frontiers in psychology·2026
Same author

Low maternal folic acid during pregnancy exacerbates ectopic fat accumulation in the liver and muscle of male offspring.

Diabetes research and clinical practice·2026
Same author

Expression of endogenous retroviral elements is associated with extracellular matrix remodeling in prostate cancer.

Mobile DNA·2026
Same author

An Empirical Dietary Inflammatory Pattern and Fecundability in a Multiethnic Asian Preconception Cohort.

The Journal of nutrition·2025

相关实验视频

Updated: Jul 2, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.3K

准HDAC6可以改善抗CD47免疫疗法.

Maria Gracia-Hernandez1, Ashutosh S Yende2, Nithya Gajendran3

  • 1Department of Biochemistry and Molecular Medicine, The George Washington University, Washington, DC, USA.

Journal of experimental & clinical cancer research : CR
|February 28, 2024
PubMed
概括

基斯脱乙酶6抑制剂 (HDAC6is) 增强巨细胞化并增强CD47免疫检查点阻塞治疗黑色素瘤. 这项研究揭示了HDAC6.

关键词:
CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47希斯脱乙酶的使用免疫治疗是一种免疫疗法.巨细胞是什么?巨细胞是什么?黑色素瘤是一种黑色素瘤.接下来的状态是A.发细胞症 (phagocytosis) 是一种致死细胞的发生.

更多相关视频

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.2K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.9K

相关实验视频

Last Updated: Jul 2, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.3K
Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.2K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.9K

科学领域:

  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.
  • 药理学 药理学是指药理学的学科.

背景情况:

  • CD47是一种免疫检查点,在癌细胞中过度表达,通过SIRPα相互作用抑制巨细胞化.
  • CD47阻断在血液癌症中表现有前途,但在黑色素瘤等固体瘤中有效性有限.
  • 基因组脱乙酶6抑制剂 (HDAC6is) 具有免疫调节特性,但它们在CD47/SIRPα轴中的作用尚不清楚.

研究的目的:

  • 为了研究HDAC6在调节CD47/SIRPα轴和巨细胞灭菌中的作用.
  • 评估HDAC6抑制与CD47阻断结合用于黑色素瘤治疗的治疗潜力.

主要方法:

  • 利用骨髓衍生的巨细胞和细胞系来评估HDAC6is对巨细胞表型和细胞发生的影响.
  • 通过使用小鼠和人类黑色素瘤细胞和巨细胞,研究了CD47/SIRPα轴调节和细胞.
  • 对黑色素瘤小鼠模型进行了体内研究,以评估Nexturastat A与抗CD47或抗SIRPα抗体相结合的抗瘤活性.

主要成果:

  • 抑制HDAC6促进了抗瘤M1巨细胞两极分化,并减少了前瘤M2表型.
  • 抑制HDAC6降低了SIRPα的表达,增加了亲细胞信号,并在黑色素瘤细胞上降低了CD47的调节.
  • 结合HDAC6抑制和抗CD47疗法在黑色素瘤模型中增强了巨细胞化和体内抗瘤活性.

结论:

  • HDAC6在调节巨细胞和天生的免疫力方面发挥着至关重要的作用.
  • HDAC6抑制剂可以强化CD47免疫检查点阻断策略用于癌症治疗.
  • 使用HDAC6is和抗CD47抗体的组合治疗在黑色素瘤中显示出显著的抗瘤活性.